IL33 and colorectal carcinoma: IL-33 is elevated in CRC, both in tissue and serum samples, and the IL-33/ST2L axis shapes immune cell populations in the tumor, promoting the accumulation or depletion of immunosuppressive and anti-tumorigenic cells, respectively [115,116].